Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 659

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling

Open access
Klein, Eric A., Cooperberg, Matthew R., Magi-Galluzzi, Cristina, Simko, Jeffry P., Falzarano, Sara M., Maddala, Tara, Chan, June M., Li, Jianbo, Cowan, Janet E., Tsiatis, Athanasios C., Cherbavaz, Diana B., Pelham, Robert J., Tenggara-Hunter, Imelda, Baehner, Frederick L., Knezevic, Dejan, Febbo, Phillip G., Shak, Steven, Kattan, Michael W., Lee, Mark, Carroll, Peter R.·2014·European Urology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2014.05.004

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Research works printed but not linked: 7

  1. Strope, 2010, Prostate cancer screening: current status and future perspectives, Nat Rev Urol, 7, 487, 10.1038/nrurol.2010.120 · doi:10.1038/nrurol.2010.120
  2. Ploussard, 2011, The contemporary concept of significant versus insignificant prostate cancer, Eur Urol, 60, 291, 10.1016/j.eururo.2011.05.006 · doi:10.1016/j.eururo.2011.05.006
  3. Magi-Galluzzi, 2007, RNA yields and RT-PCR gene expression profiles obtained from manual-microdissected, fixed-paraffin-embedded tissue (FPET) from prostate adenocarcinomas, Mod Pathol, 20, 352A
  4. Magi-Galluzzi, 2010, RNA yields and RT-PCR gene expression profiles obtained from manual-microdissected fixed paraffin-embedded prostate cancer needle core biopsies, Mod Pathol, 23, 205A
  5. Hong, 2014, Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance, Eur Urol, 66, 214, 10.1016/j.eururo.2013.08.001 · doi:10.1016/j.eururo.2013.08.001
  6. Donin, 2013, Gleason 6 prostate tumors diagnosed in the PSA era do not demonstrate the capacity for metastatic spread at the time of radical prostatectomy, Urology, 82, 148, 10.1016/j.urology.2013.03.054 · doi:10.1016/j.urology.2013.03.054
  7. Reese, 2012, The quantitative Gleason score improves prostate cancer risk assessment, Cancer, 118, 6046, 10.1002/cncr.27670 · doi:10.1002/cncr.27670

Cited by

See all 659

Metadata

Authors
Klein, E. A., Cooperberg, M. R., Magi-Galluzzi, C., Simko, J. P., Falzarano, S. M., Maddala, T., Chan, J. M., Li, J., Cowan, J. E., Tsiatis, A. C., Cherbavaz, D. B., Pelham, R. J., Tenggara-Hunter, I., Baehner, F. L., Knezevic, D., Febbo, P. G., Shak, S., Kattan, M. W., Lee, M., & Carroll, P. R.
Venue
European Urology
Publisher
Elsevier BV
Published
2014-09
Volume
66
Issue
3
Pages
550-560
ISSN
0302-2838 (ISSN-L)
OpenAlex
W2151494814
Cited by
659
References
48
FWCI
59.61
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
U.S. Department of Defense (W81XWH-13-2-0074)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling. https://app.cochat.ai/papers/10.1016/j.eururo.2014.05.004
The paper
Klein, E. A., Cooperberg, M. R., Magi-Galluzzi, C., Simko, J. P., Falzarano, S. M., Maddala, T., Chan, J. M., Li, J., Cowan, J. E., Tsiatis, A. C., Cherbavaz, D. B., Pelham, R. J., Tenggara-Hunter, I., Baehner, F. L., Knezevic, D., Febbo, P. G., Shak, S., Kattan, M. W., Lee, M., & Carroll, P. R. (2014). A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling. European Urology. https://doi.org/10.1016/j.eururo.2014.05.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.